Skip to main content
PLOS One logoLink to PLOS One
. 2016 Mar 4;11(3):e0151119. doi: 10.1371/journal.pone.0151119

Acute Effects of Particulate Air Pollution on the Incidence of Coronary Heart Disease in Shanghai, China

Xiaofang Ye 1,2,*, Li Peng 2, Haidong Kan 3, Weibing Wang 3,4, Fuhai Geng 2, Zhe Mu 2, Ji Zhou 2, Dandan Yang 2
Editor: Stephania Ann Cormier5
PMCID: PMC4778855  PMID: 26942767

Abstract

Introduction

Evidence based on ecological studies in China suggests that short-term exposure to particulate matter (PM) is associated with cardiovascular mortality. However, there is less evidence of PM-related morbidity for coronary heart disease (CHD) in China. This study aims to investigate the relationship between acute PM exposure and CHD incidence in people aged above 40 in Shanghai.

Methods

Daily CHD events during 2005–2012 were identified from outpatient and emergency department visits. Daily average concentrations for particulate matter with aerodynamic diameter less than 10 microns (PM10) were collected over the 8-year period. Particulate matter with aerodynamic diameter less than 2.5 microns (PM2.5) were measured from 2009 to 2012. Analyses were performed using quasi-poisson regression models adjusting for confounders, including long-term trend, seasonality, day of the week, public holiday and meteorological factors. The effects were also examined by gender and age group (41–65 years, and >65 years).

Results

There were 619928 CHD outpatient and emergency department visits. The average concentrations of PM10 and PM2.5 were 81.7μg/m3 and 38.6μg/m3, respectively. Elevated exposure to PM10 and PM2.5 was related with increased risk of CHD outpatients and emergency department visits in a short time course. A 10 μg/m3 increase in the 2-day PM10 and PM2.5 was associated with increase of 0.23% (95% CI: 0.12%, 0.34%) and 0.74% (95% CI: 0.44%, 1.04%) in CHD morbidity, respectively. The associations appeared to be more evident in the male and the elderly.

Conclusion

Short-term exposure to high levels of PM10 and PM2.5 was associated with increased risk of CHD outpatient and emergency department visits. Season, gender and age were effect modifiers of their association.

Introduction

Coronary heart disease (CHD), also called ischemic heart disease, could lead to sudden onset of life-threatening acute events and is associated with significant morbidity [1,2]. It is the leading cause of death in the world according to the 2010 Global Burden of Disease Study [3]. In China, the CHD prevalence has been increasing during the decades. It has reported that age-standardized mortality rate of CHD in Chinese population increased from 62.52 per 100 000 people in 1990 to 77.89 per 100 000 people in 2010, which meant there were over 900 thousand death due to CHD in 2010 [4]. In recent years, evidence of the increased risk of CHD development and exacerbation after exposure to ambient particulate matter (PM) has been provided in epidemiological studies [58]. Particulate air pollution is of similar importance as other well accepted triggers of myocardial infarction, one subtype of CHD, such as physical exertion when the exposure prevalence in the population is considered [7]. As PM exposure is ubiquitous for population, it has considerable public health relevance, especially in China where the particulate air pollution is much severe [9]. Although many studies have reported associations between short-term PM exposure and total cardiovascular mortality in several cities in China [1015], there is very scarce evidence on CHD morbidity [16]. Only one study in Shanghai has evaluated the acute effects of PM10 (particulate matter less than 10μm in aerodynamic diameter) on emergency department visits due to CHD based on one hospital data [17], which requires more large-scale studies in China as there might be different effects and/or effect magnitudes from the results in developed countries with much lower level of ambient PM.

Therefore, we performed a time-series study to investigate the acute effects of ambient PM on outpatients and emergency department visits for CHD in people aged over 40 years in Shanghai, China.

Methods

Health data

We analyzed daily CHD morbidity data in people aged above 40 years in 2005–2012 from hospital outpatient and emergency department visits in Shanghai. Data was obtained from Shanghai Health Insurance Bureau (SHIB). SHIB is the government agency in charge of the Shanghai Health Insurance System (SHIS), which provides compulsory universal health insurance to the most permanent residents in Shanghai (the coverage rate was 89.1% in 2010) [18]. As CHD diagnosis was not recorded in the SHIS for outpatient and emergency department visits, it was inferred from the medicine prescribed in the medical record, which was used for the conventional treatment of angina pectoris and myocardial infarction (MI), such as nitrates (nitroglycerin, isosorbide dinitrate), calcium channel blockers (verapamil, diltiazem) and beta-blockers (metoprolol). Nitroglycerin has been widely used for the treatment of angina and MI. Studies have reported a reduced risk of death associated with early treatment with nitroglycerin [19,20]. Verapamil and diltiazem, as vasodilators, can restore coronary artery flow and myocardial perfusion efficiently [21,22]. Beta-blocker therapy has been recommended in the course of MI for patients who are not at high risk for complications. It has revealed that metoprolol is the most frequently used beta-blocker in MI patients in China [23]. Daily CHD counts were stratified by gender and age groups (41–65 years, and >65 years).

The Institutional Review Board at the School of Public Health, Fudan University, approved the study protocol (NO. 2012-03-0324) with a waiver of informed consent. Health information was released to us at aggregate level without any potential of identifying individual patients. There was no contact with patients for this study.

Exposure data

Daily data of air pollution included PM10, particulate matter less than 2.5μm in aerodynamic diameter (PM2.5), sulfur dioxide (SO2), nitrogen dioxide (NO2) and ozone (O3). The daily average concentrations of PM10, SO2 and NO2 in 2005–2012 were obtained from Shanghai Environmental Monitoring Center. As PM2.5 and O3 were not routinely monitored as the criteria pollutants in China before 2013, the daily PM2.5 data in 2009–2012 and O3 data in 2007–2012 were got alternatively from Pudong Meteorological Service and Shanghai Center of Urban Environmental Meteorology, respectively. The daily O3 was the daily maximum values of 8-h running mean. Weather data in 2005–2012 was obtained from Shanghai Meteorological Service, including daily mean temperature and relative humidity.

Statistical analysis

Health data and exposure data were linked by date for time-series analysis. As the daily counts of CHD outpatient and emergency department visits were approximately Poisson distributed, we used a Poisson regression (quali-likelihood) in generalized linear models to estimate the association between CHD morbidity and PM exposure. The moving averaged concentrations of PM on the same day and the day before (lag 01) were used to present the main results. Data was also stratified by season (defined as warm season, May-October; and cold season, November-April). We controlled for the long-term time trend with a natural cubic regression spline with 7 degrees of freedom (df) per year [24], and 3 df per season per year for season-stratified analysis. We also controlled for day of the week and public holiday with indicator variables, and for daily temperature and relative humidity with a natural cubic spline with 4 df for each. We then added PM10 or PM2.5 with a natural cubic spline in a single pollutant model. As the CHD risk increased monotonously with ambient PM concentration, a linear effect of PM was then assumed in the model. The model is as below:

LogE(Yt)=Intercept+ns(time,df)+ns(temperature,4)+ns(humidity,4)+dow+holiday+αPMt1,t

where E(Yt) represents the expected count of CHD morbidity on day t, ns is a natural cubic spline, PMt-1,t indicates 2-day averaged concentrations of PM on day t-1 and t. Besides the main results on lag 01, PM on a single day lagged from the current day (lag 0) to the previous 6 days (lag 1 to lag 6) were also analyzed to examine the lag structure. To test the stability of PM effects on CHD morbidity, we added one of the gaseous pollutants (SO2, NO2 and O3) into the single pollutant model. We also performed a sensitivity analysis by varying the df for the time trend (from 5 to 13 df per year) to control for seasonality in the models.

Data management and regression analysis were performed with R version 3.1.0 (The R Project for Statistical Computing, http://www.r-project.org).

Results

In this study, we examined 604944 CHD outpatient and emergency department visits in people aged above 40 years. Table 1 summarizes daily CHD morbidity, PM10, PM2.5, temperature and relative humidity during 2005–2012. On average, there were 207 CHD patients visiting outpatients and emergency departments each day. Daily counts of CHD morbidity in the cold season were larger than those in the warm season. There were more female patients in the outpatient and emergency departments. Patients older than 65 years accounted for almost three quarters of the total CHD morbidity. The overall mean concentrations of PM10 and PM2.5 were 81.7 μg/m3 and 38.6 μg/m3, respectively. The concentrations of PM10 and PM2.5 were both higher in the cold season than those in the warm season. The mean temperature was 25.0°C in the warm season and 9.7°C in the cold season.

Table 1. Summary (mean ± SD) of daily CHD outpatient and emergency department visits, PM concentrations and weather conditions in Shanghai in 2005–2012.

All seasons Cold season Warm season
CHD outpatient and emergency department visits (n)
All 207.0 ± 51.1 237.8 ± 48.3 176.7 ± 32.0
Male 92.4 ± 24.9 107.0 ± 24.1 78.0 ± 15.5
Female 114.6 ± 28.5 130.8 ± 27.0 98.7 ± 19.6
41–65years 56.6 ± 12.7 61.9 ± 12.7 51.5 ± 10.5
>65years 150.4 ± 43.7 175.9 ± 42.3 125.2 ± 27.4
PM10 (μg/m3) 81.7 ± 54.4 93.8 ± 60.1 70.0 ± 45.4
PM2.5 (μg/m3)a 38.6 ± 26.7 48.7 ± 29.3 28.9 ± 19.5
Temperature (°C) 17.4 ± 9.1 9.7 ± 5.6 25.0 ± 4.3
Relative Humidity (%) 69.5 ± 12.3 67.9 ± 13.8 71.1 ± 10.4

aPM2.5 data was in 2009–2012.

Fig 1 shows the relationship between PM at lag 01 and the total CHD morbidity. In general, CHD morbidity were positively related with both PM2.5 and PM10. An approximate linear effect of PM was found for CHD morbidity. CHD morbidity monotonously increased with the 2-day averaged concentrations of PM2.5 and PM10.

Fig 1. Smoothing plots of PM2.5 (left) and PM10 (right) against CHD outpatient and emergency department visits.

Fig 1

X-axis is the PM concentrations at lag 01. The solid lines indicate the estimated mean percentage of change in daily outpatient and emergency department visits for CHD, and the dotted lines represent twice the standard error.

Table 2 presents the estimated percent of change in CHD morbidity for a 10 μg/m3 increase in 2-day averaged concentrations of PM2.5 and PM10 in different seasons. We found statistically significant associations between elevated PM exposure and increased number of CHD patients. A 10 μg/m3 increase in PM2.5 at lag 01 was associated with a 0.74% (95% CI: 0.44%, 1.04%) increase in CHD outpatient and emergency department visits, which was larger than that for PM10 with a 0.23% (95% CI: 0.12%, 0.34%) increase. There were different seasonal effects of PM on the total CHD morbidity. Significant PM effects were observed in the cold season, however, they were not statistically significant in the warm season. For instance, the estimate of the effect of PM2.5 on CHD outpatient and emergency department visits was largest in the cold season and equal to an estimated 0.93% (95% CI: 0.53%, 1.34%) increase in CHD risk per 10 μg/m3 increase in PM2.5 at lag 01 in the cold season, whereas it was nonsignificant in the warm season. Table 2 also indicates the PM effects on CHD morbidity in patients of different demographic factors. Gender and age could modify the association between PM exposure and CHD risk. The greater effect estimates were observed in men and people older than 65 years. In the cold season, there was obvious evidence of PM effects on increased risk of CHD morbidity except in people aged 41–65 years old for PM10. In the warm season, the effects of both PM2.5 and PM10 were only found in the male and the elderly.

Table 2. Estimated percent difference in CHD outpatient and emergency department visits (95% CI) in association with a 10 μg/m3 increase in PM2.5 and PM10 at lag 01 by season, gender and age group.

Group All seasons Warm season Cold season
PM2.5 PM10 PM2.5 PM10 PM2.5 PM10
All 0.74 (0.44, 1.04)* 0.23 (0.12, 0.34)* 0.40 (-0.15, 0.95) 0.17 (-0.01, 0.35) 0.93 (0.53, 1.34)* 0.28 (0.12, 0.43)*
Male 1.10 (0.72, 1.47)* 0.33 (0.19, 0.47)* 1.05 (0.35, 1.75)* 0.28 (0.05, 0.52)* 1.25 (0.78, 1.73)* 0.38 (0.20, 0.57)*
Female 0.44 (0.10, 0.79)* 0.14 (0.01, 0.27)* -0.13 (-0.76, 0.51) 0.08 (-0.14, 0.29) 0.67 (0.22, 1.13)* 0.19 (0.01, 0.36)*
41–65years 0.54 (0.09, 1.00)* 0.09 (-0.07, 0.26) -0.28 (-1.04, 0.49) 0.01 (-0.26, 0.27) 0.79 (0.22, 1.37)* 0.13 (-0.09, 0.34)
>65years 0.80 (0.47, 1.13)* 0.27 (0.15, 0.40)* 0.64 (0.00, 1.29)* 0.24 (0.03, 0.45)* 0.97 (0.54, 1.41)* 0.33 (0.17, 0.50)*

* p<0.05.

Fig 2 shows the estimated percentage of change in CHD risk for a 10 μg/m3 increase in PM10 and PM2.5 at different lag days. Across all seasons, we found that the estimates of the effects of PM2.5 and PM10 on CHD morbidity were largest at lag 0. There were increases of 0.63% (95% CI: 0.38%, 0.88%) and 0.26% (95% CI: 0.18%, 0.33%) in CHD risk for each 10 μg/m3 increase in PM2.5 and PM10 on the same day, respectively. CHD morbidity was also associated with PM2.5 at lag 1 and lag 5, with PM10 from lag 2 to lag 4.

Fig 2. Estimated percent difference in CHD outpatient and emergency department visits (95% CI) in association with a 10 μg/m3 increase in PM10 and PM2.5 by lag days.

Fig 2

Table 3 compares the results of single PM models with models adjusted for other gaseous pollutants. After controlling for SO2, NO2 or O3, the PM2.5 effects on CHD morbidity generally remained statistically significant, although the magnitude increased for SO2 and decreased for NO2. The estimates of effects of PM2.5 and PM10 changed slightly after O3 was added in the models. The PM10 effects on CHD morbidity tended to be insignificant after adjustment for SO2 and NO2. The choice of df for the time trend from 5 to 13 per year did not substantially affect the estimates of the effects of PM on CHD outpatient and emergency department visits (data not shown).

Table 3. Estimated percent difference in CHD outpatient and emergency department visits (95% CI) in association with a 10 μg/m3 increase in PM2.5 and PM10 with or without adjustment for gaseous pollutants.

Adjustment PM2.5 PM10
Without adjustment 0.74 (0.44, 1.04)* 0.23 (0.12, 0.34)*
Adjusted for SO2 1.09 (0.63, 1.55)* 0.07(-0.07, 0.21)
Adjusted for NO2 0.59 (0.16, 1.02)* -0.04(-0.18, 0.10)
Adjusted for O3 0.73 (0.42, 1.03)* 0.23 (0.10, 0.35)*

* p<0.05.

Discussion

Although there are many studies investigated the association between ambient PM exposure and CHD morbidity and mortality in the US, the UK and other developed countries where PM concentration is quite low [25,26], evidence is limited with regard to the effects at higher levels of particulate air pollution. This study supports significant effects of both PM10 and PM2.5 on the acute onset and exacerbation of CHD, and also provides evidence of increased CHD risk at high elevated PM. This study, to our knowledge, is one of the few studies in China to evaluate the acute effects of PM on CHD morbidity [2,17,27,28].

Our results are mostly consistent with previous studies which reported significantly detrimental effects of particulate air pollution [6,26]. Studies in US and European cities have found high risk of CHD events due to recent PM exposure [1]. For example, Zanobetti et al [29] found an increase of 2.25% (95%CI: 1.10%, 3.42%) in MI admissions for a 10 μg/m3 increase in 2-day averaged PM2.5 concentration in 26 US communities. In our study, the effect estimate was slightly smaller, with only 0.74% (95% CI: 0.44%, 1.04%) increase in CHD outpatient and emergency department visits per 10 μg/m3 increase in PM2.5. The PM2.5 concentration was shown under 20μg/m3 in most US communities, almost half of the level in Shanghai in our study. The different effect magnitudes may be due to pollution level and population susceptibility in different locations, which was suggested in both US and China that the exposure-response function between cardiovascular mortality and PM exposure was relatively steep at very low levels of exposure and flattened out at higher exposure levels [30,31].

Two types of hospital visits, outpatient and emergency department visits, were combined together to be analyzed in this study. Their ratio was about 10%. Outpatient visits are usually not regarded as a good outcome in epidemiological studies of acute effects of air pollution in the US and Europe, where they are scheduled by appointment. However, situation is different in China. Outpatient visits are unscheduled as emergency department visits, and are first-come first-served. Patients could receive timely medical service in either outpatient or emergency departments. Therefore, the combined records of outpatient and emergency department visits in our study may have the potential to reflect the true morbidity information and offer opportunity to evaluate the acute effects of particulate air pollution.

An immediate impact on CHD of increased level of both PM2.5 and PM10 was found in the concurrent day (lag 0) and the previous day (lag 1), which was consistent with studies conducted in other locations showing a short time course [32,33]. We also observed the largest increase in CHD morbidity at lag 0 for PM exposure, which suggested an even shorter than daily timescale for PM effect on CHD incidence. Although it is impossible to assess the association on sub-daily level in this study, some studies have documented increased risk in hours after exposure to elevated PM [34,35].

Analyses by season indicated that effect estimates were higher in the cold season. A few studies found the modification of season or temperature on the PM-related effects on cardiovascular morbidity and mortality [36,37]. Our findings of a stronger association between particulate air pollution and cardiovascular risk in the cold season were consistent with previous studies in Shanghai [17,38]. The enhanced effects on ischemic heart disease in cool and dry weather were also indicated in Hong Kong [39]. One possible explanation is related to low temperature and increased blood pressure and viscosity in the cold season, which could be important causal factors in increasing winter morbidity and mortality due to heart attacks and strokes [40,41]. Another possible reason is the varying source and composition of PM in different seasons. In Shanghai, the prevailing wind direction is northwestern to northern in the cold season and southeast to east in the warm season, respectively [42]. The northern air flow transports high concentration PM2.5 emitted from coal burning for residential heating and biomass burning in the northern China in the cold season, while the eastern air flow which comes from the East China Sea carries clean air in summer [43]. For example, BC aerosol mass of non-local sources transported to Shanghai was highest in winter [44].

Stronger effects were observed in the elderly and male patients in the study. It is easy to understand the elderly are more vulnerable to particulate air pollution. Gender is usually treated as an effect modifier in air pollution epidemiology [45]. However results of previous studies on gender-specific effects of PM on CHD were conflicting [17,46]. Particulate air pollution showed higher CHD risk in the male in this study, which may be related to high exposure level of air pollution and tobacco smoking in men than women in China [47].

It is a challenge to elucidate the underling mechanisms of the PM effects on CHD, however, several possible mechanisms have been suggested in experimental studies and epidemiological studies. One potential mechanism is systemic inflammation, which is closely associated with cardiovascular diseases [48]. It has been shown that levels of inflammation markers such as high-sensitivity C-reactive protein increased significantly after exposure to particulate air pollution [49,50]. Increase in oxidative stress [51], endothelial dysfunction [52], blood viscosity [53,54] due to particulate exposure were also reported. They can accelerate the progression of atherosclerosis, cause the plaque instable, promote the formation of thrombosis, and increase the susceptibility to CHD. The other one potential mechanism is the impaired cardiac autonomic system as a result of particulate exposure. A reduced heart rate variability is usually treated as a marker of cardiac autonomic dysfunction. Studies on the association between short-term exposure to particulate air pollution and heart rate variability have supported an inverse relationship [55].

There are several limitations in this study. Firstly, the CHD records in outpatient and emergency department visits were not diagnosed according to ICD-10 but on medication prescription, which made misclassification with other cardiovascular diseases unavoidable, although the medicine was ascertained by several clinicians in hospitals. Hypertension could be included partly in this study as beta-blockers and calcium channel blockers have the effect of reducing blood pressure. Secondly, we used one monitoring data of PM2.5 for only 4 years, different from the city-wide PM10 data for 8 years. PM2.5 data from one monitoring station may has measurement error and introduce bias to our results.

In summary, in this time-series study coving large amount of CHD outpatient and emergency department visits in Shanghai during 2005–2012, we found that particulate air pollution (PM10 and PM2.5) was statistically significantly associated with increased CHD risk. Furthermore, the PM effects were higher in the cold season, the male and those over 65 years. These findings provide new evidence of high PM level on CHD incidence and may suggest further investigation on specific cardiovascular diseases in China.

Acknowledgments

The authors thank the Shanghai Health Insurance Bureau for their contribution of health data clearance and management to this study, and thank Dr. Hui Zhang from Shanghai Tenth People’s Hospital of Tongji University for her professional suggestion on the health data management.

Data Availability

Air pollution data used in this study are obtained from Shanghai Environmental Monitoring Center, which could also be accessed from the website (http://www.envir.gov.cn/airnews/index.asp) according to individual API (Air Pollution Index) of each pollutant. Daily meteorological data are freely available. The health data we used for this study are not publicly available. With a proper ethics approval, the data can be obtained by contacting Ms. Airong Wang (Email: war71@126.com) at Shanghai Health Insurance Bureau, which provides anonymized and de-identified health administrative data to researchers.

Funding Statement

This study was funded by the Scientific Research Program Science and Technology Commission of Shanghai Municipality (Grant No. 12dz1202600) and the Global Environment Change Research of Fudan University Tyndall Centre (Grant No. EZH1829007/003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Brook RD, Rajagopalan S, Pope CA 3rd, Brook JR, Bhatnagar A, Diez-Roux AV, et al. Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation. 2010. June 1;121(21):2331–78. 10.1161/CIR.0b013e3181dbece1 [DOI] [PubMed] [Google Scholar]
  • 2.R384 Xie W, Li G, Zhao D, Xie X, Wei Z, Wang W, et al. Relationship between fine particulate air pollution and ischaemic heart disease morbidity and mortality. Heart (British Cardiac Society). 2015. February;101(4):257–63. . [DOI] [PubMed] [Google Scholar]
  • 3.Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012. December 15;380(9859):2095–128. 10.1016/S0140-6736(12)61728-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Liu J, Liu Y, Wang L, Yin P, Liu S, You J, et al. [The disease burden of cardiovascular and circulatory diseases in China, 1990 and 2010]. Chi J Prev Med. 2015;49(4):315–20. . Chinese. [PubMed] [Google Scholar]
  • 5.Wolf K, Schneider A, Breitner S, Meisinger C, Heier M, Cyrys J, et al. Associations between short-term exposure to particulate matter and ultrafine particles and myocardial infarction in Augsburg, Germany. Int J Hyg Environ Health. 2015. May 11;218(6):535–42. 10.1016/j.ijheh.2015.05.002 [DOI] [PubMed] [Google Scholar]
  • 6.Mustafic H, Jabre P, Caussin C, Murad MH, Escolano S, Tafflet M, et al. Main air pollutants and myocardial infarction: a systematic review and meta-analysis. JAMA. 2012. February 15;307(7):713–21. 10.1001/jama.2012.126 [DOI] [PubMed] [Google Scholar]
  • 7.Nawrot TS, Perez L, Kunzli N, Munters E, Nemery B. Public health importance of triggers of myocardial infarction: a comparative risk assessment. Lancet. 2011. February 26;377(9767):732–40. 10.1016/S0140-6736(10)62296-9 [DOI] [PubMed] [Google Scholar]
  • 8.Martinelli N, Olivieri O, Girelli D. Air particulate matter and cardiovascular disease: a narrative review. Eur J Intern Med. 2013. June;24(4):295–302. 10.1016/j.ejim.2013.04.001 [DOI] [PubMed] [Google Scholar]
  • 9.Ma Z, Hu X, Sayer AM, Levy R, Zhang Q, Xue Y, et al. Satellite-based spatiotemporal trends in PM2.5 concentrations: China, 2004–2013. Environ Health Perspect. 2015. July 24 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Cao J, Xu H, Xu Q, Chen B, Kan H. Fine particulate matter constituents and cardiopulmonary mortality in a heavily polluted Chinese city. Environ Health Perspect. 2012. March;120(3):373–8. Pubmed Central PMCID: PMC3295342. 10.1289/ehp.1103671 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Chen R, Pan G, Kan H, Tan J, Song W, Wu Z, et al. Ambient air pollution and daily mortality in Anshan, China: a time-stratified case-crossover analysis. Sci Total Environ. 2010. November 15;408(24):6086–91. 10.1016/j.scitotenv.2010.09.018 [DOI] [PubMed] [Google Scholar]
  • 12.Guo Y, Barnett AG, Zhang Y, Tong S, Yu W, Pan X. The short-term effect of air pollution on cardiovascular mortality in Tianjin, China: comparison of time series and case-crossover analyses. Sci Total Environ. 2010. December 15;409(2):300–6. 10.1016/j.scitotenv.2010.10.013 [DOI] [PubMed] [Google Scholar]
  • 13.Zhang P, Dong G, Sun B, Zhang L, Chen X, Ma N, et al. Long-term exposure to ambient air pollution and mortality due to cardiovascular disease and cerebrovascular disease in Shenyang, China. PLoS One. 2011;6(6):e20827 Pubmed Central PMCID: PMC3112212. 10.1371/journal.pone.0020827 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Breitner S, Liu L, Cyrys J, Bruske I, Franck U, Schlink U, et al. Sub-micrometer particulate air pollution and cardiovascular mortality in Beijing, China. Sci Total Environ. 2011. November 15;409(24):5196–204. 10.1016/j.scitotenv.2011.08.023 [DOI] [PubMed] [Google Scholar]
  • 15.Zhang Y, Guo Y, Li G, Zhou J, Jin X, Wang W, et al. The spatial characteristics of ambient particulate matter and daily mortality in the urban area of Beijing, China. Sci Total Environ. 2012. October 1;435–436:14–20. 10.1016/j.scitotenv.2012.06.092 [DOI] [PubMed] [Google Scholar]
  • 16.Lu F, Xu D, Cheng Y, Dong S, Guo C, Jiang X, et al. Systematic review and meta-analysis of the adverse health effects of ambient PM2.5 and PM10 pollution in the Chinese population. Environ Res. 2015. January;136:196–204. 10.1016/j.envres.2014.06.029 [DOI] [PubMed] [Google Scholar]
  • 17.Xie J, He M, Zhu W. Acute effects of outdoor air pollution on emergency department visits due to five clinical subtypes of coronary heart diseases in Shanghai, China. J Epidemiol. 2014;24(6):452–9. . Pubmed Central PMCID: PMC4213219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Shanghai Statistical Yearbook 2012: China Statistics Press; 2012. [Google Scholar]
  • 19.Strandmark R, Herlitz J, Axelsson C, Claesson A, Bremer A, Karlsson T, et al. Determinants of pre-hospital pharmacological intervention and its association with outcome in acute myocardial infarction. Scand J Trauma Resusc Emerg Med. 2015;23(1):105 . Pubmed Central PMCID: PMC4665872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Perez MI, Musini VM, Wright JM. Effect of early treatment with anti-hypertensive drugs on short and long-term mortality in patients with an acute cardiovascular event. Cochrane Database Syst Rev. 2009. (4):CD006743 10.1002/14651858.CD006743.pub2 [DOI] [PubMed] [Google Scholar]
  • 21.Wang L, Cheng Z, Gu Y, Peng D. Short-term effects of verapamil and diltiazem in the treatment of no reflow phenomenon: a meta-analysis of randomized controlled trials. Biomed Res Int. 2015;2015:382086 Pubmed Central PMCID: PMC4609355. 10.1155/2015/382086 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Huang D, Qian J, Ge L, Jin X, Jin H, Ma J, et al. REstoration of COronary flow in patients with no-reflow after primary coronary interVEntion of acute myocaRdial infarction (RECOVER). Am Heart J. 2012. September;164(3):394–401. 10.1016/j.ahj.2012.06.015 [DOI] [PubMed] [Google Scholar]
  • 23.Zhang H, Masoudi FA, Li J, Wang Q, Li X, Spertus JA, et al. National assessment of early beta-blocker therapy in patients with acute myocardial infarction in China, 2001–2011: The China Patient-centered Evaluative Assessment of Cardiac Events (PEACE)-Retrospective AMI Study. Am Heart J. 2015. September;170(3):506–15 e1. 10.1016/j.ahj.2015.05.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Wang X, Chen R, Meng X, Geng F, Wang C, Kan H. Associations between fine particle, coarse particle, black carbon and hospital visits in a Chinese city. Sci Total Environ. 2013. April 29;458-460C:1–6. . [DOI] [PubMed] [Google Scholar]
  • 25.Milojevic A, Wilkinson P, Armstrong B, Bhaskaran K, Smeeth L, Hajat S. Short-term effects of air pollution on a range of cardiovascular events in England and Wales: case-crossover analysis of the MINAP database, hospital admissions and mortality. Heart. 2014. July;100(14):1093–8. Pubmed Central PMCID: PMC4078678. 10.1136/heartjnl-2013-304963 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Dominici F, Peng RD, Bell ML, Pham L, McDermott A, Zeger SL, et al. Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases. JAMA. 2006. March 8;295(10):1127–34. . Pubmed Central PMCID: PMC3543154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Pun VC, Yu IT, Ho KF, Qiu H, Sun Z, Tian L. Differential effects of source-specific particulate matter on emergency hospitalizations for ischemic heart disease in Hong Kong. Environ Health Perspect. 2014. April;122(4):391–6. Pubmed Central PMCID: PMC3984224. 10.1289/ehp.1307213 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Yu IT, Qiu H, Wang X, Tian L, Tse LA. Synergy between particles and nitrogen dioxide on emergency hospital admissions for cardiac diseases in Hong Kong. Int J Cardiol. 2013. October 3;168(3):2831–6. 10.1016/j.ijcard.2013.03.082 [DOI] [PubMed] [Google Scholar]
  • 29.Zanobetti A, Franklin M, Koutrakis P, Schwartz J. Fine particulate air pollution and its components in association with cause-specific emergency admissions. Environ Health. 2009;8:58 Pubmed Central PMCID: PMC2807856. 10.1186/1476-069X-8-58 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Pope CA 3rd, Burnett RT, Krewski D, Jerrett M, Shi Y, Calle EE, et al. Cardiovascular mortality and exposure to airborne fine particulate matter and cigarette smoke: shape of the exposure-response relationship. Circulation. 2009. September 15;120(11):941–8. 10.1161/CIRCULATIONAHA.109.857888 [DOI] [PubMed] [Google Scholar]
  • 31.Chen R, Kan H, Chen B, Huang W, Bai Z, Song G, et al. Association of particulate air pollution with daily mortality: the China Air Pollution and Health Effects Study. Am J Epidemiol. 2012. June 1;175(11):1173–81. 10.1093/aje/kwr425 [DOI] [PubMed] [Google Scholar]
  • 32.Belleudi V, Faustini A, Stafoggia M, Cattani G, Marconi A, Perucci CA, et al. Impact of fine and ultrafine particles on emergency hospital admissions for cardiac and respiratory diseases. Epidemiology. 2010. May;21(3):414–23. 10.1097/EDE.0b013e3181d5c021 [DOI] [PubMed] [Google Scholar]
  • 33.Nuvolone D, Balzi D, Chini M, Scala D, Giovannini F, Barchielli A. Short-term association between ambient air pollution and risk of hospitalization for acute myocardial infarction: results of the cardiovascular risk and air pollution in Tuscany (RISCAT) study. Am J Epidemiol. 2011. July 1;174(1):63–71. 10.1093/aje/kwr046 [DOI] [PubMed] [Google Scholar]
  • 34.Peters A, Dockery DW, Muller JE, Mittleman MA. Increased particulate air pollution and the triggering of myocardial infarction. Circulation. 2001. June 12;103(23):2810–5. . [DOI] [PubMed] [Google Scholar]
  • 35.Bhaskaran K, Hajat S, Armstrong B, Haines A, Herrett E, Wilkinson P, et al. The effects of hourly differences in air pollution on the risk of myocardial infarction: case crossover analysis of the MINAP database. BMJ. 2011;343:d5531 Pubmed Central PMCID: PMC3176903. 10.1136/bmj.d5531 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Dai L, Zanobetti A, Koutrakis P, Schwartz JD. Associations of fine particulate matter species with mortality in the United States: a multicity time-series analysis. Environ Health Perspect. 2014. August;122(8):837–42. Pubmed Central PMCID: PMC4123030. 10.1289/ehp.1307568 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Nawrot TS, Torfs R, Fierens F, De Henauw S, Hoet PH, Van Kersschaever G, et al. Stronger associations between daily mortality and fine particulate air pollution in summer than in winter: evidence from a heavily polluted region in western Europe. J Epidemiol Community Health. 2007. February;61(2):146–9. . Pubmed Central PMCID: PMC2465652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Kan H, London SJ, Chen G, Zhang Y, Song G, Zhao N, et al. Season, sex, age, and education as modifiers of the effects of outdoor air pollution on daily mortality in Shanghai, China: The Public Health and Air Pollution in Asia (PAPA) Study. Environ Health Perspect. 2008. September;116(9):1183–8. Pubmed Central PMCID: PMC2535620. 10.1289/ehp.10851 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Qiu H, Yu IT, Wang X, Tian L, Tse LA, Wong TW. Cool and dry weather enhances the effects of air pollution on emergency IHD hospital admissions. Int J Cardiol. 2013. September 20;168(1):500–5. 10.1016/j.ijcard.2012.09.199 [DOI] [PubMed] [Google Scholar]
  • 40.Kyobutungi C, Grau A, Stieglbauer G, Becher H. Absolute temperature, temperature changes and stroke risk: a case-crossover study. Eur J Epidemiol. 2005;20(8):693–8. . [DOI] [PubMed] [Google Scholar]
  • 41.Hoffmann B, Luttmann-Gibson H, Cohen A, Zanobetti A, de Souza C, Foley C, et al. Opposing effects of particle pollution, ozone, and ambient temperature on arterial blood pressure. Environ Health Perspect. 2012. February;120(2):241–6. Pubmed Central PMCID: 3279434. 10.1289/ehp.1103647 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Li M, Huang X, Zhu L, Li J, Song Y, Cai X, et al. Analysis of the transport pathways and potential sources of PM10 in Shanghai based on three methods. Sci Total Environ. 2012. January 1;414:525–34. 10.1016/j.scitotenv.2011.10.054 [DOI] [PubMed] [Google Scholar]
  • 43.Zhao M, Huang Z, Qiao T, Zhang Y, Xiu G, Yu J. Chemical characterization, the transport pathways and potential sources of PM2.5 in Shanghai: Seasonal variations. Atmos Res. 2015;158–159:66–78. [Google Scholar]
  • 44.Wang H, Kang Y, He Q, Chen Y. Transport of black carbon aerosols from non-local sources: A case study in Shanghai. Particuology. 2015;20:89–93. [Google Scholar]
  • 45.Clougherty JE. A growing role for gender analysis in air pollution epidemiology. Environ Health Perspect. 2010. February;118(2):167–76. Pubmed Central PMCID: PMC2831913. 10.1289/ehp.0900994 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Zanobetti A, Schwartz J. The effect of particulate air pollution on emergency admissions for myocardial infarction: a multicity case-crossover analysis. Environ Health Perspect. 2005. August;113(8):978–82. . Pubmed Central PMCID: PMC1280336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Wang R, Zhu L, Yan W, Zeng G, Michael E. The influence of estimated retail tobacco sale price increase on smokers' smoking habit in Jiangxi province, China: a cross-sectional study. Tob Induc Dis. 2015;13(1):25 Pubmed Central PMCID: PMC4545555. 10.1186/s12971-015-0043-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Ridker PM, Morrow DA. C-reactive protein, inflammation, and coronary risk. Cardiology clinics. 2003. August;21(3):315–25. . [DOI] [PubMed] [Google Scholar]
  • 49.Ruckerl R, Greven S, Ljungman P, Aalto P, Antoniades C, Bellander T, et al. Air pollution and inflammation (interleukin-6, C-reactive protein, fibrinogen) in myocardial infarction survivors. Environ Health Perspect. 2007. July;115(7):1072–80. . Pubmed Central PMCID: PMC1913563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Zhao J, Gao Z, Tian Z, Xie Y, Xin F, Jiang R, et al. The biological effects of individual-level PM2.5 exposure on systemic immunity and inflammatory response in traffic policemen. Occup Environ Med. 2013. January 15 . [DOI] [PubMed] [Google Scholar]
  • 51.Sorensen M, Daneshvar B, Hansen M, Dragsted LO, Hertel O, Knudsen L, et al. Personal PM2.5 exposure and markers of oxidative stress in blood. Environ Health Perspect. 2003. February;111(2):161–6. . Pubmed Central PMCID: PMC1241344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Zhao J, Xie Y, Qian X, Jiang R, Song W. Acute effects of fine particles on cardiovascular system: differences between the spontaneously hypertensive rats and wistar kyoto rats. Toxicol Lett. 2010. March 1;193(1):50–60. 10.1016/j.toxlet.2009.12.002 [DOI] [PubMed] [Google Scholar]
  • 53.Wu S, Deng F, Wei H, Huang J, Wang H, Shima M, et al. Chemical constituents of ambient particulate air pollution and biomarkers of inflammation, coagulation and homocysteine in healthy adults: a prospective panel study. Part Fibre Toxicol. 2012;9:49 Pubmed Central PMCID: PMC3585865. 10.1186/1743-8977-9-49 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Schicker B, Kuhn M, Fehr R, Asmis LM, Karagiannidis C, Reinhart WH. Particulate matter inhalation during hay storing activity induces systemic inflammation and platelet aggregation. Eur J Appl Physiol. 2009. March;105(5):771–8. 10.1007/s00421-008-0962-9 [DOI] [PubMed] [Google Scholar]
  • 55.Pieters N, Plusquin M, Cox B, Kicinski M, Vangronsveld J, Nawrot TS. An epidemiological appraisal of the association between heart rate variability and particulate air pollution: a meta-analysis. Heart. 2012. August;98(15):1127–35. Pubmed Central PMCID: PMC3392690. 10.1136/heartjnl-2011-301505 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Air pollution data used in this study are obtained from Shanghai Environmental Monitoring Center, which could also be accessed from the website (http://www.envir.gov.cn/airnews/index.asp) according to individual API (Air Pollution Index) of each pollutant. Daily meteorological data are freely available. The health data we used for this study are not publicly available. With a proper ethics approval, the data can be obtained by contacting Ms. Airong Wang (Email: war71@126.com) at Shanghai Health Insurance Bureau, which provides anonymized and de-identified health administrative data to researchers.


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES